Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $21.2800 (1.24%) ($20.6100 - $21.6000) on Tue. Mar. 7, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.5% (three month average) | RSI | 64 | Latest Price | $21.2800(1.24%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -3.1% a day on average for past five trading days. | Weekly Trend | EDIT declines -3.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) ARKG(62%) IBB(61%) XBI(60%) IWO(56%) ARKK(55%) | Factors Impacting EDIT price | EDIT will decline at least -2.75% in a week (0% probabilities). VIXM(-13%) TLT(-6%) SHY(-5%) GDXJ(-4%) UUP(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.75% (StdDev 5.5%) | Hourly BBV | 0 () | Intraday Trend | 1.3% | | | |
|
Resistance Level | $22.32 | 5 Day Moving Average | $22.51(-5.46%) | 10 Day Moving Average | $23.07(-7.76%) | 20 Day Moving Average | $22.32(-4.66%) | To recent high | -22% | To recent low | 36.7% | Market Cap | $1.322b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |